VP
Schedule 13G filing
Vanguard Portfolio Management LLC disclosed a 8.6% stake in RARE
Vanguard Portfolio Management LLC reported owning 8.6% of Ultragenyx Pharmaceutical Inc. (RARE) (8,481,266 shares) in a Schedule 13G filed Oct 30, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 30, 2026
- Source
- Schedule 13G
More RARE insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.